Fundz

Check-Cap to merge with MBody AI for tech expansion

PUBLIC · MBAIJun 29, 2026

Acquiring Company

Check-Cap Ltd

Acquired Company

MBody AI

IsraelBiotechnologyHealthcareHealth CareMedicalMedical DeviceHealth DiagnosticsInformation TechnologyArtificial IntelligenceMachine LearningRobotics

Description

Check-Cap Ltd. and MBody AI Corp. are advancing a merger that has been approved by shareholders of both companies. The business combination is expected to enhance Check-Cap's operations as a leader in embodied artificial intelligence. Nasdaq's initial review of the listing application is ongoing, subject to customary conditions. Completion of the transaction aims to strengthen capabilities in autonomous robotic solutions.

Who to call at Check-Cap Ltd, and when

When Check-Cap Ltd changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Check-Cap Ltd raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Check-Cap Ltd, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Check-Cap Ltd

Location

29 ABBA HUSHI AVENUE

Israel

About

Check-Cap (NASDAQ: CHEK) is a clinical stage medical diagnostics company aiming to redefine colorectal cancer (CRC) screening through the introduction of C-Scan®, the first and only patient-friendly preparation-free screening test to detect polyps before they may transform into colorectal cancer and enable early intervention and cancer prevention.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Check-Cap Ltd makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Check-Cap Ltd's next move

Learn about Strategic plan

Frequently asked

Who acquired MBody AI?

MBody AI was acquired by Check-Cap Ltd, based in Israel. The deal was reported on June 29, 2026. Check-Cap Ltd is publicly traded (MBAI) and operates in Biotechnology.

When did Check-Cap Ltd acquire MBody AI?

Check-Cap Ltd's acquisition of MBody AI was reported on June 29, 2026. Check-Cap Ltd. and MBody AI Corp. are advancing a merger that has been approved by shareholders of both companies. The business combination is expected to enhance Check-Cap's operations as a leader in embodied artificial intelligence. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does MBody AI do?

MBody AI focuses on embodied AI technology. The company aims to innovate for the autonomous workforce. Its innovative approaches are set to transform the industry. It is publicly traded (MBAI), operating in Information Technology.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.